2022-08-18 Trend pattern changed from расходящийся клин с наклоном вверх to сужающийся канал.
2022-08-18 Signal in Stochastic changed from bullish recovery to bearish. The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.
2022-08-18 Signal in MACD changed from bullish to bearish recovery. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: entry into the oversold zone.
2022-08-18 Signal in RSI changed from bullish recovery to bearish recovery. RSI indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.
2022-08-18 Signal in EMA100 changed from bullish reversal to bearish reversal. 2022-07-12 the price crossed down the moving average line and formed a short-term downside trend.
2022-08-18 Signal in EMA50 changed from bullish reversal to bearish reversal. 2022-07-08 the price crossed down the moving average line and formed a short-term downside trend.
2022-08-18 Signal in EMA20 changed from bullish reversal to bearish reversal. 2022-07-08 the price crossed down the moving average line and formed a short-term downside trend.
2022-08-18 Trend Power changed from strong to slow.
Current temperature: 13.01
ST: 0, Cor:
total | Sell | Sell | - |
---|---|---|---|
rsi | ActivelyBuy | - | - |
macd | Sell | Sell | - |
stoch | Sell | - | - |
ma20 | Sell | - | - |
ma50 | Sell | - | - |
ma100 | Sell | - | - |
Candlestick Pattern | March 8, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision. | ||
ISIN | GB0009252882 |
---|---|
ceo | Ms. Sally Jackson |
Website | https://www.gsk.com |